Specialized Enteral Formulas in Acute and Chronic Pulmonary Disease
- 2 December 2009
- journal article
- research article
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 24 (6) , 666-674
Abstract
The relationship between pulmonary disease and nutrition is significant. Nutrition support therapy is common in this patient population as a supportive and/or therapeutic measure. Historical reports of adverse respiratory function associated with high parenteral carbohydrate intakes have been the rationale for using high‐fat enteral formulas in patients with chronic pulmonary dysfunction. Theoretically, providing a low‐carbohydrate formula will reduce carbon dioxide production, result in a reduced respiratory quotient, and lead to associated improvement in pulmonary outcomes. In the patient with acute respiratory distress syndrome, an imbalance of mediators exists, with proinflammatory mediators being dominant, ultimately affecting the disease course. An enteral formula with modified lipids designed to modulate eicosanoid production, and therefore influence the inflammatory cascade, is available. This article reviews the rationale for use of modified enteral formulas in both chronic and acute pulmonary disease, reviews the available studies evaluating the efficacy of these formulas, and provides overall recommendations for the use of specialized enteral formulas in individuals with pulmonary disease.Keywords
This publication has 39 references indexed in Scilit:
- The Use of an Inflammation‐Modulating Diet in Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome: A Meta‐Analysis of Outcome DataJournal of Parenteral and Enteral Nutrition, 2008
- Nutrition Therapy for Acute Respiratory Distress SyndromeJournal of Parenteral and Enteral Nutrition, 2008
- Nonventilatory Interventions in the Acute Respiratory Distress SyndromeJournal of Intensive Care Medicine, 2008
- Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock*Critical Care Medicine, 2006
- Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury*Critical Care Medicine, 2006
- Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndromeJournal of Parenteral and Enteral Nutrition, 2003
- To the EditorNutrition in Clinical Practice, 1998
- Is a Pulmonary Enteral Formula Warranted for Patients With Pulmonary Dysfunction?Nutrition in Clinical Practice, 1997
- Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic ratsCritical Care Medicine, 1997
- High fat, low carbohydrate, enteral feeding in patients weaning from the ventilatorIntensive Care Medicine, 1994